Tuberculosis

"As a doctor fighting to treat HIV/AIDS and TB, I need medical innovation to happen"

Charles, two and half years old, died recently. He'd been brought to the MSF clinic in Mathare, infamous as the poorest slum in Kenya. He was HIV positive and also infected with tuberculosis (TB). Here in Kenya, like elsewhere in Africa and throughout the developing world, we are struggling to treat patients with inadequate medical tools.  Dr Liesbet Ohler berates a system that has failed to deliver the medicines that might have saved Charles and could save millions more. Click here

New Drug Trials for Drug-Resistant TB

In a series of papers published by PLoS, international experts explain how innovative trials in patients with drug resistant TB could speed up delivery of new drugs, explore how to fill up the current TB pipeline with additional promising drugs and call for building of clinical trial capacity in developing countries.

Paper on Randomized drug trials

Paper on New approaches to filling drug pipeline

Paper on Building clinical trials capacity

 

Treating drug resistant TB in Uzbekistan

© Donald Weber

In Karakalpakstan, a semi-autonomous region of Uzbekistan, MSF works with the local health authorities to treat patients with MDR TB. Recent results have thrown up some alarming statistics about the spread of an even more resistant strain of TB – extensively drug resistant TB or XDR TB

click here. to listen to Dr Kai Braker, MSF 's medical advisor to the project.  

Dying for a Test

© Brendan Bannon

Martine Usdin, biologist with the MSF Access Campaign explains what needs to be done to improve TB diagnostics now and in the future. Click here

Click here to read MSF's analysis of the TB diagnostics pipeline

 

Tuberculosis in China

(c) Henrik Braam/MSF

One quarter of the world's TB cases are in China and drug resistant TB is on the rise. Click here to read more about TB in China

 

MSF and Tuberculosis